Skip to search Skip to main content
  • About Us
    Vision Our Story Technology Focus Areas Our Team
  • Access
    Policies Guides Events COVID-19 Advisory
  • Collections
    Books & Journals A-Z listing Special Collections
  • Contact Us
  1. Jio Institute Digital Library
  2. Searchworks

Searchworks

Select search scope, currently: Articles
  • Catalog
    books, media & more in Jio Institute collections
  • Articles
    journal articles & other e-resources

Help
Contact
Covid-19 Advisory
Policies
  • Bookmarks 0
  • Search history
  • Sign in

Cite

Safety and efficacy of apalutamide in Japanese patients with metastatic castration‐sensitive prostate cancer receiving androgen deprivation therapy: Final report for the Japanese subpopulation analysis of the randomized, placebo‐controlled, phase III TITAN study

MLA

Uemura, Hirotsugu, et al. “Safety and Efficacy of Apalutamide in Japanese Patients with Metastatic Castration‐sensitive Prostate Cancer Receiving Androgen Deprivation Therapy: Final Report for the Japanese Subpopulation Analysis of the Randomized, Placebo‐controlled, Phase III TITAN Study.” International Journal of Urology, vol. 29, no. 6, June 2022, pp. 533–40. EBSCOhost, https://doi.org/10.1111/iju.14843.



APA

Uemura, H., Arai, G., Uemura, H., Suzuki, H., Aoyama, J., Hatayama, T., Ito, M., Lefresne, F., McCarthy, S., Mundle, S., He, J., & Chi, K. N. (2022). Safety and efficacy of apalutamide in Japanese patients with metastatic castration‐sensitive prostate cancer receiving androgen deprivation therapy: Final report for the Japanese subpopulation analysis of the randomized, placebo‐controlled, phase III TITAN study. International Journal of Urology, 29(6), 533–540. https://doi.org/10.1111/iju.14843



Chicago

Uemura, Hirotsugu, Gaku Arai, Hiroji Uemura, Hiroyoshi Suzuki, Junya Aoyama, Tomoyoshi Hatayama, Miku Ito, et al. 2022. “Safety and Efficacy of Apalutamide in Japanese Patients with Metastatic Castration‐sensitive Prostate Cancer Receiving Androgen Deprivation Therapy: Final Report for the Japanese Subpopulation Analysis of the Randomized, Placebo‐controlled, Phase III TITAN Study.” International Journal of Urology 29 (6): 533–40. doi:10.1111/iju.14843.

Contact
Covid-19 Advisory
Policies
About Us
Academics
Research
Campus Life
Contact
T&C
Privacy Policy